These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20561650

  • 1. [Transfer factors in medical therapy].
    Sánchez-González DJ, Sosa-Luna CA, Vásquez-Moctezuma I.
    Med Clin (Barc); 2011 Sep 10; 137(6):273-7. PubMed ID: 20561650
    [Abstract] [Full Text] [Related]

  • 2. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ, Reymond JF, Häcki MA, Frey-Wettstein M.
    MMW Munch Med Wochenschr; 1975 Mar 28; 117(13):517-24. PubMed ID: 805916
    [Abstract] [Full Text] [Related]

  • 3. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study.
    Prasad U, bin Jalaludin MA, Rajadurai P, Pizza G, De Vinci C, Viza D, Levine PH.
    Biotherapy; 1996 Mar 28; 9(1-3):109-15. PubMed ID: 8993768
    [Abstract] [Full Text] [Related]

  • 4. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP.
    Immunology; 1979 Jan 28; 36(1):1-12. PubMed ID: 369991
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First experience with immunomodulation in septic shock.
    Josten C, Muhr G, Sistermann R.
    Prog Clin Biol Res; 1989 Jan 28; 308():989-94. PubMed ID: 2528747
    [No Abstract] [Full Text] [Related]

  • 10. Glatiramer acetate for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 1997 Jul 04; 39(1004):61-2. PubMed ID: 9217693
    [No Abstract] [Full Text] [Related]

  • 11. Transfer factor: Potential for therapy of malignant diseases.
    Neidhart JA, LoBuglio AF.
    Arch Otolaryngol; 1975 Nov 04; 101(11):664-6. PubMed ID: 1200907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfer factors: identification of conserved sequences in transfer factor molecules.
    Kirkpatrick CH.
    Mol Med; 2000 Apr 04; 6(4):332-41. PubMed ID: 10949913
    [Abstract] [Full Text] [Related]

  • 14. Long-term transfer-factor treatment for multiple sclerosis.
    Fog T, Pedersen L, Raun NE, Kam-Hansen S, Mellerup E, Platz P, Ryder LP, Jakobsen BK, Grob P.
    Lancet; 1978 Apr 22; 1(8069):851-3. PubMed ID: 76798
    [Abstract] [Full Text] [Related]

  • 15. The study of human transfer factor.
    Li ZL.
    Sci Sin B; 1985 Apr 22; 28(4):394-401. PubMed ID: 4012263
    [Abstract] [Full Text] [Related]

  • 16. ["Transfer factor" in ophthalmology (author's transl)].
    Rocha H.
    Klin Monbl Augenheilkd; 1977 Jul 22; 171(1):63-70. PubMed ID: 302878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transfer factor therapy of thoracic sarcoidosis.
    Vezendi S, Schröder I.
    Allergol Immunopathol (Madr); 1989 Jul 22; 17(1):35-7. PubMed ID: 2750639
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.